HIGHLIGHTS
- who: TYPE and collaborators from the Universitu00e9 catholique de LouvainBiotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu have published the research: Editorial: Targeting the PD-1/ PD-L1 cancer immune evasion axis: Challenges and emerging strategies, Volume II, in the Journal: (JOURNAL) of 23/Nov/2022
- what: The aim of this Research Topic is to highlight novel and significant discoveries in the field of cancer immunotherapy, extending the understanding of the mechanisms of ICI-induced anti-cancer immunity, thereby improving therapeutic responses of ICBT and reducing the propensity for adverse events.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.